Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


Articles published in J Investig Allergol Clin Immunol

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    April 2019
  1. ALVAREZ-PUEBLA MJ, Arroabarren E, Zavala MJ, Corcuera A, et al
    Responses to biological therapies in eosinophilic severe asthma.
    J Investig Allergol Clin Immunol. 2019 Apr 16:0. doi: 10.18176/jiaci.0403.
    PubMed     Text format    


  2. DAVILA I, Quirce S, Olaguibel JM
    Selection of biologics in severe asthma: a multifaceted algorithm.
    J Investig Allergol Clin Immunol. 2019 Apr 10:0. doi: 10.18176/jiaci.0398.
    PubMed     Text format    


  3. TIOTIU A, Thaon I, Poussel M, Penven E, et al
    Occupational asthma caused by powder paint in the automotive industry.
    J Investig Allergol Clin Immunol. 2019 Apr 8:0. doi: 10.18176/jiaci.0394.
    PubMed     Text format    


  4. BLANCO APARICIO M, Delgado Romero J, Molina Paris J, Gomez Saenz JT, et al
    Referral criteria for asthma: Consensus document.
    J Investig Allergol Clin Immunol. 2019 Apr 1:0. doi: 10.18176/jiaci.0393.
    PubMed     Text format     Abstract available


  5. TIOTIU A, Oster JP, Roux P, Nguyen Thi PL, et al
    Omalizumab's effectiveness in severe allergic asthma and nasal polyps: a real-life study.
    J Investig Allergol Clin Immunol. 2019 Apr 1:0. doi: 10.18176/jiaci.0391.
    PubMed     Text format     Abstract available


    February 2019
  6. URRUTIA I, Delgado J, Dominguez-Ortega J, Mascaros E, et al
    Clinical factors associated with the overuse of asthma rescue medication.
    J Investig Allergol Clin Immunol. 2019 Feb 11:0. doi: 10.18176/jiaci.0387.
    PubMed     Text format     Abstract available


  7. SANCHEZ-JARENO M, Barranco P, Romero D, Dominguez-Ortega J, et al
    Severe Eosinophilic Allergic Asthma Responsive to Mepolizumab After Failure of 2 Consecutive Biologics.
    J Investig Allergol Clin Immunol. 2019;29:79-81.
    PubMed     Text format    


  8. VALERO A, Olaguibel J, Delgado J, Plaza V, et al
    Dilemmas and New Paradigms in Asthma Management.
    J Investig Allergol Clin Immunol. 2019;29:15-23.
    PubMed     Text format     Abstract available


    January 2019
  9. CAMINATI M, Vianello A, Chieco Bianchi F, Festi G, et al
    Relevance of Th2 markers in the assessment and therapeutic management of severe allergic asthma: a real life perspective.
    J Investig Allergol Clin Immunol. 2019 Jan 24:0. doi: 10.18176/jiaci.0379.
    PubMed     Text format     Abstract available


    December 2018
  10. GOMULKA K, Liebhart J, Jaskula E, Lange A, et al
    VEGF -2549 -2567 del18 polymorphism and irreversible bronchoconstriction in asthmatics.
    J Investig Allergol Clin Immunol. 2018 Dec 21:0. doi: 10.18176/jiaci.0369.
    PubMed     Text format     Abstract available


  11. BOBOLEA I, Arismendi E, Valero A, Agusti A, et al
    Early Life Origins of Asthma: A Review of Potential Effectors.
    J Investig Allergol Clin Immunol. 2018 Dec 18:0. doi: 10.18176/jiaci.0361.
    PubMed     Text format     Abstract available


  12. MARQUES-MEJIAS MA, Tomas-Perez M, Hernandez I, Lopez I, et al
    Asthma Exacerbations in the Pediatric Emergency Department at a Tertiary Hospi-tal: Relationship with Environmental Factors.
    J Investig Allergol Clin Immunol. 2018 Dec 18:0. doi: 10.18176/jiaci.0364.
    PubMed     Text format     Abstract available


    November 2018
  13. VALERO A, Olaguibel J, Delgado J, Plaza V, et al
    Re-evolution of asthma management: dilemmas and new paradigms.
    J Investig Allergol Clin Immunol. 2018 Nov 9:0. doi: 10.18176/jiaci.0345.
    PubMed     Text format     Abstract available


    October 2018
  14. MARQUES-MEJIAS MA, Barranco P, Laorden D, Romero D, et al
    Worsening of Severe Asthma Due to Menstruation and Sensitization to Albumins.
    J Investig Allergol Clin Immunol. 2018;28:330-332.
    PubMed     Text format    


    September 2018
  15. GARCIA-RIO F, Alvarez-Puebla MJ, De Esteban I, Barranco P, et al
    Obesity and asthma. Key clinical questions.
    J Investig Allergol Clin Immunol. 2018 Sep 17:0. doi: 10.18176/jiaci.0316.
    PubMed     Text format     Abstract available


    August 2018
  16. SUBIZA J, Kilimajer J, Barjau C, Bravo F, et al
    Occupational Asthma Caused by Actinia equina.
    J Investig Allergol Clin Immunol. 2018;28:277-278.
    PubMed     Text format    


  17. CAMINATI M, Senna G, Vianello A, Ricci G, et al
    Thunderstorm Asthma: A Critical Appraisal Based on Clinical Practice.
    J Investig Allergol Clin Immunol. 2018;28:273-275.
    PubMed     Text format    


    June 2018
  18. KUROSAWA M, Sutoh E
    Prospective Open-Label Study of 48-Week Subcutaneous Administration of Mepolizumab in Japanese Patients with Severe Eosinophilic Asthma.
    J Investig Allergol Clin Immunol. 2018 Jun 29:0. doi: 10.18176/jiaci.0285.
    PubMed     Text format     Abstract available


  19. KANEMITSU Y, Matsumoto H, Oguma T, Nagasaki T, et al
    Independent factors contributing to the daytime and nighttime asthmatic cough refractory to inhaled corticosteroids.
    J Investig Allergol Clin Immunol. 2018 Jun 29:0. doi: 10.18176/jiaci.0281.
    PubMed     Text format     Abstract available


  20. ALVAREZ PUEBLA MJ, Aroabarren Aleman E, Corcuera Garcia A, Ibanez Bereiz B, et al
    Blood Eosinophils, Fraction of Exhaled Nitric Oxide, and Serum Eosinophil Cationic Protein as Surrogate Markers for Sputum Eosinophils in Asthma: Influence of Treatment With Inhaled Corticosteroids.
    J Investig Allergol Clin Immunol. 2018;28:210-212.
    PubMed     Text format    


    May 2018
  21. BAI S, Hua L, Wang X, Liu Q, et al
    Association of a four-locus gene model including IL13, IL4, FCER1B, and ADRB2 with the Asthma Predictive Index and atopy in Chinese Han children.
    J Investig Allergol Clin Immunol. 2018 May 11:0. doi: 10.18176/jiaci.0272.
    PubMed     Text format     Abstract available


    April 2018
  22. KIM S, Nam Jin K, Cho SH, Hyun Lee C, et al
    Severe Asthma Phenotypes Classified by Site of Airway Involvement and Remodeling via Chest CT Scan.
    J Investig Allergol Clin Immunol. 2018 Apr 18:0. doi: 10.18176/jiaci.0265.
    PubMed     Text format     Abstract available


    January 2018
  23. RIJAVEC M, Zavbi M, Lopert A, Flezar M, et al
    GLCCI1 polymorphism rs37973 and asthma treatment response to inhaled corticosteroids.
    J Investig Allergol Clin Immunol. 2018 Jan 17:0. doi: 10.18176/jiaci.0229.
    PubMed     Text format     Abstract available


  24. D AMATO M, Cecchi L, Annesi-Maesano I, D Amato G, et al
    News on Climate change, air pollution and allergic trigger factors of asthma.
    J Investig Allergol Clin Immunol. 2018 Jan 17:0. doi: 10.18176/jiaci.0228.
    PubMed     Text format     Abstract available


  25. NIETO-FONTARIGO JJ, Gonzalez-Barcala FJ, San-Jose ME, Cruz MJ, et al
    Expansion of a CD26(low) effector TH subset and reduction of circulating levels of sCD26 in stable allergic asthma in adults.
    J Investig Allergol Clin Immunol. 2018 Jan 3:0. doi: 10.18176/jiaci.0224.
    PubMed     Text format     Abstract available


    November 2017
  26. SEO YEON Y, Yoon Hee K, Min Kwang B, Hyung Jung K, et al
    Repeated Fractional Exhaled Nitric Oxide Measurements Is Not Essential for Asthma Screening.
    J Investig Allergol Clin Immunol. 2017 Nov 28:0. doi: 10.18176/jiaci.0215.
    PubMed     Text format     Abstract available


    January 2017
  27. SPOSATO B, Scalese M, Milanese M, Masieri S, et al
    Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma.
    J Investig Allergol Clin Immunol. 2017;27:388-391.
    PubMed     Text format    


  28. LARCO-ROJAS X, Gonzalez-Gutierrez ML, Vazquez-Cortes S, Bartolome B, et al
    Occupational Asthma and Urticaria in a Fishmonger Due to Creatine Kinase, a Cross-Reactive Fish Allergen.
    J Investig Allergol Clin Immunol. 2017;27:386-388.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: